Physician profile
Charles Keller
NPI 1558324392
$7,058.66
in general payments reported to CMS, 2019-2025
19 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $715 · 2021: $424 · 2022: $185 · 2023: $4,860 · 2024: $103 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,675 · Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,675.00 |
| Food and Beverage | $536.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,163.71 | 2019-2025 | Rocklatan, Clareon |
| Carl Zeiss Meditec, INC. | $474.79 | 2019-2020 | |
| Abbvie INC. | $229.90 | 2022-2025 | |
| Allergan, INC. | $214.64 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $147.60 | 2019-2023 | Tecnis Iol |
| Ocular Therapeutix, INC. | $90.70 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $90.57 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $89.42 | 2019-2021 | |
| Sight Sciences, INC. | $83.26 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $73.05 | 2021-2024 | Idose |
| Thea Pharma INC. | $68.37 | 2023-2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $60.97 | 2021 | |
| Horizon Therapeutics Plc | $58.46 | 2022-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $57.13 | 2019 | |
| Bausch & Lomb Americas INC. | $41.76 | 2022-2025 | Envista Envy Iol |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $37.78 | 2019-2025 | |
| Dompe US, INC. | $32.24 | 2022 | |
| Eyevance Pharmaceuticals LLC | $22.81 | 2023 | Flarex |
| Sun Pharmaceutical Industries INC. | $21.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.